Telesis Bio Inc (TBIO)
4.42
+0.07
(+1.61%)
USD |
NASDAQ |
May 17, 16:00
4.42
0.00 (0.00%)
After-Hours: 20:00
Telesis Bio Revenue (Quarterly): 3.44M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.44M |
| December 31, 2023 | 6.977M |
| September 30, 2023 | 5.564M |
| June 30, 2023 | 8.652M |
| March 31, 2023 | 6.316M |
| December 31, 2022 | 9.469M |
| September 30, 2022 | 6.675M |
| June 30, 2022 | 5.655M |
| March 31, 2022 | 5.636M |
| Date | Value |
|---|---|
| December 31, 2021 | 3.078M |
| September 30, 2021 | 2.786M |
| June 30, 2021 | 2.852M |
| March 31, 2021 | 2.327M |
| December 31, 2020 | 1.937M |
| September 30, 2020 | 1.635M |
| June 30, 2020 | 1.617M |
| March 31, 2020 | 1.387M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.387M
Minimum
Mar 2020
9.469M
Maximum
Dec 2022
4.471M
Average
3.44M
Median
Mar 2024
Revenue (Quarterly) Benchmarks
| Ainos Inc | 0.0207M |
| OpGen Inc | 0.699M |
| Zomedica Corp | 6.262M |
| LENSAR Inc | 10.59M |
| Eargo Inc (DELISTED) | 8.27M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.637M |
| Total Expenses (Quarterly) | 11.96M |
| EPS Diluted (Quarterly) | -5.52 |
| Enterprise Value | 27.04M |
| Gross Profit Margin (Quarterly) | 42.03% |
| Profit Margin (Quarterly) | -251.1% |
| Earnings Yield | -626.7% |
| Normalized Earnings Yield | -508.77 |